{{Rsnum
|rsid=1386498
|Gene=TPH2
|Chromosome=12
|position=72004363
|Orientation=plus
|GMAF=0.4986
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=TPH2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 16.9 | 35.6 | 47.5
| HCB | 28.9 | 34.8 | 36.3
| JPT | 17.9 | 33.9 | 48.2
| YRI | 37.4 | 44.9 | 17.7
| ASW | 23.2 | 53.6 | 23.2
| CHB | 28.9 | 34.8 | 36.3
| CHD | 33.9 | 41.3 | 24.8
| GIH | 25.7 | 30.7 | 43.6
| LWK | 50.9 | 39.8 | 9.3
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 27.0 | 40.0 | 33.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21396719
|Title=Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}